title: Discrepant results in plasma, but not serum in the Beckman Coulter DxI Access HYPERsensitive hTSH 3rd generation assay affect the management of differentiated thyroid cancer and hyperthyroid patients.
authors.forename: Jessica M
authors.initials: JM
authors.lastname: Colón-Franco
authors.forename: Rita
authors.initials: R
authors.lastname: Goodlett
authors.forename: Elbert
authors.initials: E
authors.lastname: Cox
authors.forename: Alison
authors.initials: A
authors.lastname: Woodworth
mesh_terms: D000704:Analysis of Variance; D002498:Centrifugation; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy; D007118:Immunoassay; D008163:Luminescent Measurements; D009367:Neoplasm Staging; D010949:Plasma / Q000737:chemistry*; D011247:Pregnancy; D011933:Reagent Kits, Diagnostic; D044967:Serum / Q000737:chemistry*; D013964:Thyroid Neoplasms / Q000188:drug therapy* / Q000473:pathology; D013972:Thyrotropin / Q000097:blood* / Q000627:therapeutic use
chemical_list: D011933:Reagent Kits, Diagnostic; D013972:Thyrotropin